COMPOSITION AND USE OF CANNABIS EXTRACTS FOR CHILDHOOD EPILEPSY IN THEN AUSTRALIAN COMMUNITY
A. SURAEV, N. LINTZERIS, J. STUART, R. C. KEVIN, R.BLACKBURN, E. RICHARDS, J. C. ARNOLD, C. IRELAND, L. TODD, D. J. ALLSOP & I. S. Mc GREGOR
SCIENTIFIC REPORTS VOLUME 8, ARTICLE NUMBER: 10154 (2018)
The study collected data from 65 families to explore their experiences with medicinal cannabis to help treat their children’s epilepsy. It showed that a significant proportion of families reported cannabis extracts being “effective” in reducing their child’s seizure burden and improving their general condition. Despite limitations of the study the findings warrant further investigation into cannabinoids in treatment-resistant epilepsy.
Pre-clinical studies documenting the anti-cancer effects of THC and its success in inhibiting cancer growth and spread have been on the rise. Clinical studies however are scarce as the psychoactive effects of THC can limit its medicinal and clinical use. Could non-psychoactive cannabinoids found in cannabis and hemp be the answer to treating cancer instead?
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.